The Blood and Marrow Transplant Program at Northside Hospital (NH-BMT) provides the best of both worlds—clinical excellence and compassionate care. We are committed to being the premier program in the Southeast, providing exceptional, state-of-the-art care to patients undergoing acute leukemia treatment, CAR T-cell immunotherapy, and blood and marrow stem cell transplantation. New patient brochure
2024 National Leaders in Allogeneic Transplantation
NH-BMT is the ONLY BMT program in the country and the only BMT program in Georgia to have achieved survival outcomes that significantly exceeded the expected survival rate for allogeneic and unrelated donor transplants for the last 16 consecutive reporting cycles (2009–2024) and is one of only 12 national centers (less than 10% of all centers) to over-perform for the current annual reporting cycle.
The Program’s actual one-year survival rate, as reported in the December 2024 Center for International Blood and Marrow Transplant Research (CIBMTR) final 2024 Transplant Center Specific Survival Report and nmdp.org is 82.6%.*
For additional survival data details, visit bmtga.com/bmt-survival-data.
*Survival information includes only patients who received their first allogeneic transplant between January 1, 2020 and December 31, 2022, using unrelated or related donors and who had reported follow-up.
Northside Hospital Blood & Marrow, Leukemia, and Immunotherapy Programs Achieve Major 2025 ASH Meeting Milestone
The Northside Hospital Blood & Marrow, Leukemia, and Immunotherapy programs are proud to announce that 23 oral and poster abstracts have been accepted for presentation at the upcoming American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
This outstanding achievement reflects the dedication, expertise, and collaboration of our exceptional teams—including the Clinical Research Team, led by Caitlin Guzowski, Manager; the Data Management Team, led by Katie Jackson, Manager; our BMTGA physicians and team members; and, most importantly, our patients, whose courage and participation make these advances possible.
Celebrating Survivorship at the 2025 Northside Hospital BMT and CAR T-Cell Reunion
The 2025 Northside Hospital Blood and Marrow Transplant (BMT) and CAR T-Cell Survivor’s Reunion was recently held at the Georgia Aquarium, bringing together more than 800 attendees for an unforgettable celebration. The evening was filled with emotion—tears, joy, laughter, and even a surprise marriage proposal!
Guests were inspired by heartfelt speeches from an allogeneic acute leukemia transplant survivor celebrating 27 years since transplant, a sickle cell transplant survivor marking two years of renewed health, and a devoted caregiver and platelet donor who shared a powerful perspective on giving and gratitude.
We extend our deepest thanks to our dedicated physicians, staff, and—most importantly—our true heroes: our patients and their caregivers. Your strength, resilience, and hope continue to inspire us every day.
Northside brings breakthrough Melanoma treatment to Atlanta
Northside Hospital is leading the way to bringing advanced cancer immunotherapies, like Tumor Infiltrating Lymphocyte (TIL) therapy, to Georgia. FOX LOCAL host Alyse Eady talks to Dr. Liza Bachier about the breakthrough Melanoma treatment.
TIL Therapy: Harnessing the Body’s Own Immune System to Treat Metastatic Melanoma
Tumor Infiltrating Lymphocyte (TIL) therapy uses the body’s natural immune response to fight cancer. TILs are immune cells that our body makes to attack cancer and the treatment is now approved for patients with metastatic melanoma.
Here’s how it works: physicians collect lymphocytes from a patient’s tumor and expand them outside the body until they reach billions in number. Once enough cells are grown, they’re reintroduced into the patient to help control the disease and in some cases put it into remission.
Bill’s story: Advanced cancer care offered hope close to home
When Bill Clark of Avondale Estates, then 65 years old, thinks back to the spring of 2020, he remembers a life that felt full and steady. He was in excellent health, leading a thriving architectural and engineering firm and enjoying time with family and friends in Atlanta. Then, just as the world was adjusting to the challenges of COVID-19, Bill’s life changed dramatically. What started as concerning inflammation near his left eye quickly led to a diagnosis that would define the next five years — conjunctival melanoma, a rare and aggressive cancer.
Bill recalled, “The diagnosis was shocking. I knew melanoma was serious. I had friends who had it and didn’t survive it.”
Patient Stories
From pain to hope: A sickle cell survivor's journey
Chelsea Uche, a 23-year-old sickle cell survivor, shares her inspiring journey from diagnosis to overcoming the challenges of living with this inherited blood disorder. Diagnosed with sickle cell shortly after birth, Chelsea describes how the disease affected her physically, emotionally and socially.
“Growing up with sickle cell, I had a very tough time with everything, truthfully. I was in the hospital consistently. I suffered with very bad chronic pain,” she said. Click Here to read full interview
Natalie’s story: From diagnosis to double transplant
After battling uterine fibroids, Natalie Grubbs was unexpectedly diagnosed with acute lymphoblastic leukemia, followed by a rare secondary cancer that required two stem cell transplants. Here, the Atlanta resident shares her story in her own words — from diagnosis and treatment to healing, hope and resilience. What are the events that led up to your cancer diagnosis?
Before my cancer diagnosis, I had suffered from uterine fibroids for years. The fibroids caused miscarriages, a distended abdomen and excruciating periods with extremely heavy.......Click Here to read full interview
Momta's story: Surviving leukemia and heart failure
In 1993, while living in New York City, Momta Jahan was diagnosed with and treated for acute myeloid leukemia (AML). It was a challenging time for her. With two young daughters — ages 7 1/2 years and 13 months — Momta said she had no choice but to fight for her life. Thankfully, she achieved complete remission. In 1997, Momta and her family moved to Clarkston, Georgia. Then, in late August 2021, she began feeling weak and fatigued and noticed she was bruising easily.Click Here to read full interview
